Catamenial pneumothorax is a rarely encountered entity characterized by recurrent pneumothorax concurrent with menstruation. Numerous mechanisms have been postulated in the etiology of catamenial pneumothorax and treatment is still controversial. We report a case of a catamenial pneumothorax successfully treated with a Gn-RH analogue supporting the efficacy of this regimen and the endometriosis theory as an underlying cause of the disease.

Slabbynck H, Laureys M, Impens N, De Vroey P, Schandevyl W: Recurring catamenial pneumothorax treated with a Gn-Rh analogue. Chest 1991;100:851.
Blanco S, Hernando F, Gomez A, Gonzalez MJ, Torres AJ, Balibrea JL: Catamenial pneumothorax caused by diaphragmatic endometriosis. J Thorac Cardiovasc Surg 1998;116:179–180.
Maurer ER, Schaal JA, Mendez FL: Chronic recurring spontaneous pneumothorax due to endometriosis of the diaphragm. JAMA 1958;168:2013–2014.
Carter EJ, Ettensohn DB: Catamenial pneumothorax. Chest 1990;98:713–716.
Fonseca P: Catamenial pneumothorax: A multifactorial etiology. J Thorac Cardiovasc Surg 1998;116:872–873.
Markham SM, Carpenter SE, Rock JA: Extrapelvic endometriosis. Obstet Gynecol Clin North Am 1989;16:193–219.
Grevy C, Andersen HJ, Hansen LG, Bloch AV: Catamenial pneumothorax. Thorac Cardiovasc Surg 1987;35:238–239.
Van Schil PE, Vercauteren SR, Vermeire PA, Nackaerts YH, Van Marck EA: Catamenial pneumothorax caused by thoracic endometriosis. Ann Thorac Surg 1996;62:585–586.
Garris PD, Sokol MS, Kelly K, Whitman GF, Plouffe L Jr: Leuprolide acetate treatment of catamenial pneumothorax. Fertil Steril 1994;61:173–174.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.